These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 558109)

  • 1. [2-o-Iodotyrosine]-oxytocin and [2-o-methyltyrosine]-oxytocin: basic pharmacology and comments on their potential use in binding studies.
    Pliska V; Marbach P; Vasák J; Rudinger J
    Experientia; 1977 Mar; 33(3):367-9. PubMed ID: 558109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
    Walter R; Havran RT; Schwartz IL
    J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
    Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
    J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
    Smith CW; Skala G; Walter R
    J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin.
    Atke A; Vilhardt H
    Acta Endocrinol (Copenh); 1987 May; 115(1):155-60. PubMed ID: 3035851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active-site studies of neurohypophyseal hormones: synthesis and pharmacological properties of [5-(N4,N4-dimethylasparagine)]oxytocin.
    Walter R; Stahl GL; Caplaneris T; Cordopatis P; Theodoropoulos D
    J Med Chem; 1979 Jul; 22(7):890-3. PubMed ID: 448689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin analogs with oxygen-containing side chains in position 3.
    Gazis D; Schwartz IL; Cordopatis P; Theodoropoulos D
    Int J Pept Protein Res; 1986 Jun; 27(6):679-84. PubMed ID: 3759339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin and lysine-vasopressin with N5,N5-dialkylglutamine in the 4 position: effect of introducing sterically hindered groups into the hydrophilic cluster of neurohypophyseal hormones.
    Stahl GL; Smith CW; Walter R; Tsegenidis T; Stavropoulos G; Cordopatis P; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):213-7. PubMed ID: 7359537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin.
    Lowbridge J; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1979 May; 22(5):565-9. PubMed ID: 458806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
    Smith CW; Botos CR; Skala G; Walter R
    J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk-ejecting and uterotonic activities of oxytocin analogues in rats.
    Barth T; Jost K; Rychlík I
    Endocrinol Exp; 1975 Jan; 9(1):35-42. PubMed ID: 179784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350).
    Oka T; Nakanishi A; Okada T
    Jpn J Pharmacol; 1975 Feb; 25(1):15-24. PubMed ID: 1152307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined high oxytocic with negligible antidiuretic and pressor activities in multisubstituted oxytocins.
    Stahl GL; Walter R
    J Med Chem; 1977 Apr; 20(4):492-5. PubMed ID: 850233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.